中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
2,4,5-三甲氧基苯甲醛 | asaraldehyde | 4460-86-0 | C10H12O4 | 196.203 |
3-(溴甲基)-1,2,4,5-四甲氧基苯 | 3-(bromomethyl)-1,2,4,5-tetramethoxybenzene | 86489-89-6 | C11H15BrO4 | 291.142 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (2,3,5,6-tetramethoxyphenyl)methanol | 181819-59-0 | C11H16O5 | 228.245 |
3-(溴甲基)-1,2,4,5-四甲氧基苯 | 3-(bromomethyl)-1,2,4,5-tetramethoxybenzene | 86489-89-6 | C11H15BrO4 | 291.142 |
—— | (E)-2-(2,3,5,6-tetramethoxystyryl)phenol | 1210341-30-2 | C18H20O5 | 316.354 |
Antioxidants have potential for the treatment of stroke and neurodegeneration, and chimeric compounds that combine a flavon-3-ol head group related to myricetin and a lipophilic decyl tail are known to protect membranes from oxidative damage at least as well as vitamin E. New flavon-3-ols that are highly hydroxylated in the B ring in ways not found in natural flavon-3-ols and bearing a lipophilic decyl tail have been prepared from trimethoxy- and tetramethoxybenzoic acids accessed by lithiation–carboxylation reactions. Direct enolate acylation was preferred over Baker–Venkataraman rearrangement when there were methoxy groups at both the 2- and the 6-position of the benzoic acid derivatives.